{"id":"https://openalex.org/W1997012194","doi":"https://doi.org/10.1111/j.1365-2516.2005.01055.x","title":"A Bayesian approach to the assessment of inhibitor risk in studies of factor VIII concentrates","display_name":"A Bayesian approach to the assessment of inhibitor risk in studies of factor VIII concentrates","publication_year":2005,"publication_date":"2005-01-01","ids":{"openalex":"https://openalex.org/W1997012194","doi":"https://doi.org/10.1111/j.1365-2516.2005.01055.x","mag":"1997012194","pmid":"https://pubmed.ncbi.nlm.nih.gov/15660982"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2516.2005.01055.x","doi":"https://doi.org/10.1111/j.1365-2516.2005.01055.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2516.2005.01055.x","pdf_url":null,"source":{"id":"https://openalex.org/S37667796","display_name":"Haemophilia","issn_l":"1351-8216","issn":["1351-8216","1355-0691","1365-2516"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Haemophilia","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037787790","display_name":"Marcia Lee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"M. L. Lee","raw_affiliation_strings":["UCLA School of Public Heath, Los Angeles, CA, USA. martin.l.lee@att.net","UCLA School of Public Heath, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA School of Public Heath, Los Angeles, CA, USA. martin.l.lee@att.net","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"UCLA School of Public Heath, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034488510","display_name":"David A. Roth","orcid":"https://orcid.org/0000-0001-8356-0457","observed_orcids":["https://orcid.org/0000-0001-8356-0457"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. A. Roth","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA","Wyeth Research, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"]},{"raw_affiliation_string":"Wyeth Research, Cambridge, MA, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5037787790"],"corresponding_institution_ids":["https://openalex.org/I161318765"],"apc_list":{"value":4760,"currency":"USD","value_usd":4760},"apc_paid":null,"fwci":0.3744,"has_fulltext":false,"cited_by_count":24,"citation_normalized_percentile":{"value":0.62972196,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"11","issue":"1","first_page":"5","last_page":"12"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/factor-viii-concentrate","display_name":"factor VIII concentrate","score":0.9610000252723694},{"id":"https://openalex.org/keywords/factor-viii-inhibitors","display_name":"factor VIII inhibitors","score":0.7400000095367432},{"id":"https://openalex.org/keywords/hemophilia-treatment","display_name":"hemophilia treatment","score":0.6259999871253967},{"id":"https://openalex.org/keywords/clinical-trial-design","display_name":"clinical trial design","score":0.6290000081062317}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5982271432876587},{"id":"https://openalex.org/C107673813","wikidata":"https://www.wikidata.org/wiki/Q812534","display_name":"Bayesian probability","level":2,"score":0.5863951444625854},{"id":"https://openalex.org/C19351080","wikidata":"https://www.wikidata.org/wiki/Q1395034","display_name":"New product development","level":2,"score":0.5418418645858765},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.5309020280838013},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.5143662691116333},{"id":"https://openalex.org/C90673727","wikidata":"https://www.wikidata.org/wiki/Q901718","display_name":"Product (mathematics)","level":2,"score":0.4567055404186249},{"id":"https://openalex.org/C82789193","wikidata":"https://www.wikidata.org/wiki/Q2142611","display_name":"Relative risk","level":3,"score":0.4413127601146698},{"id":"https://openalex.org/C12174686","wikidata":"https://www.wikidata.org/wiki/Q1058438","display_name":"Risk assessment","level":2,"score":0.4251537024974823},{"id":"https://openalex.org/C177264268","wikidata":"https://www.wikidata.org/wiki/Q1514741","display_name":"Set (abstract data type)","level":2,"score":0.4126429557800293},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3681270480155945},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1426372528076172},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.12679404020309448},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.11546367406845093},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.0},{"id":"https://openalex.org/C162853370","wikidata":"https://www.wikidata.org/wiki/Q39809","display_name":"Marketing","level":1,"score":0.0},{"id":"https://openalex.org/C38652104","wikidata":"https://www.wikidata.org/wiki/Q3510521","display_name":"Computer security","level":1,"score":0.0},{"id":"https://openalex.org/C2524010","wikidata":"https://www.wikidata.org/wiki/Q8087","display_name":"Geometry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D001499","descriptor_name":"Bayes Theorem","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005165","descriptor_name":"Factor V","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006467","descriptor_name":"Hemophilia A","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006467","descriptor_name":"Hemophilia A","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012680","descriptor_name":"Sensitivity and Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019774","descriptor_name":"Blood Coagulation Factor Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1365-2516.2005.01055.x","doi":"https://doi.org/10.1111/j.1365-2516.2005.01055.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2516.2005.01055.x","pdf_url":null,"source":{"id":"https://openalex.org/S37667796","display_name":"Haemophilia","issn_l":"1351-8216","issn":["1351-8216","1355-0691","1365-2516"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Haemophilia","raw_type":"journal-article"},{"id":"pmid:15660982","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15660982","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Haemophilia : the official journal of the World Federation of Hemophilia","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":13,"referenced_works":["https://openalex.org/W11544889","https://openalex.org/W55755498","https://openalex.org/W1479881385","https://openalex.org/W1537744156","https://openalex.org/W2035920001","https://openalex.org/W2047123804","https://openalex.org/W2143958714","https://openalex.org/W2150424701","https://openalex.org/W2324395680","https://openalex.org/W3112590807","https://openalex.org/W4229491312","https://openalex.org/W4237438296","https://openalex.org/W4323282389"],"related_works":["https://openalex.org/W2532754884","https://openalex.org/W2567029634","https://openalex.org/W7120316360","https://openalex.org/W1542045857","https://openalex.org/W2528291253","https://openalex.org/W2295917217","https://openalex.org/W3163388506","https://openalex.org/W1901485325","https://openalex.org/W1561686313","https://openalex.org/W7160122354"],"abstract_inverted_index":{"The":[0],"assessment":[1,34],"of":[2,13,30,35,56,70,80,99,128,144],"inhibitor":[3,38,64,100,155,191],"risk":[4,39,98,156,192],"is":[5,139,166],"a":[6,24,44,121,133,145,161,186],"crucial":[7],"component":[8],"in":[9,40,150],"the":[10,28,33,54,68,78,142,148,170],"clinical":[11],"development":[12],"new":[14,51],"and":[15,32,37,50,83],"modified":[16],"factor":[17],"VIII":[18],"(FVIII)":[19],"preparations.":[20],"There":[21],"has":[22,153],"been":[23,60],"recent":[25,45],"discussion":[26],"about":[27],"design":[29],"studies":[31,42],"inhibitors":[36],"such":[41],"at":[43],"FDA-sponsored":[46],"FVIII":[47,107],"Inhibitor":[48],"Workshop,":[49],"requirements":[52,82],"for":[53,86],"success":[55],"these":[57,81,118],"trials":[58],"have":[59,93],"proposed":[61],"to":[62,89],"evaluate":[63],"data":[65],"based":[66,131,140],"on":[67,132,141],"use":[69],"an":[71,94,110,125,154],"upper":[72],"95%":[73],"confidence":[74,172],"bound.":[75],"We":[76,175],"review":[77],"consequences":[79],"demonstrate":[84],"that":[85,147,163,177],"any":[87],"product":[88,149,187],"succeed,":[90],"it":[91],"must":[92],"extremely":[95],"low":[96],"underlying":[97],"development.":[101],"Furthermore,":[102],"several":[103],"existing":[104,179],"commercially":[105],"available":[106],"products":[108,180],"with":[109,189],"excellent":[111],"safety":[112],"record":[113],"would":[114,181,193],"not":[115],"necessarily":[116],"pass":[117,182],"endpoints.":[119],"As":[120],"result,":[122],"we":[123,164],"propose":[124],"alternative":[126],"set":[127],"acceptance":[129],"criteria":[130],"Bayesian":[134],"statistical":[135],"paradigm.":[136],"This":[137],"approach":[138],"determination":[143],"probability":[146],"question":[151],"actually":[152],"below":[157],"some":[158],"pre-set":[159],"limit,":[160],"concept":[162],"believe":[165],"more":[167],"intuitive":[168],"than":[169],"traditional":[171],"interval":[173],"method.":[174],"show":[176],"all":[178],"this":[183],"approach,":[184],"but":[185],"(Bisinact)":[188],"known":[190],"not.":[194]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}